Orally bioavailable BTK PROTAC active against wild-type and C481 mutant BTKs in human lymphoma CDX mouse models YS Lim, SM Yoo, V Patil, HW Kim, HH Kim, B Suh, JY Park, N Jeong, ... Blood Advances 7 (1), 92-105, 2023 | 17 | 2023 |
Discovery of harmalanium halides as anti‐ovarian cancer agents Y Choi, SH Ji, V Patil, EH Kim, H Park, SH Kim, P Kim Bulletin of the Korean Chemical Society 43 (4), 559-563, 2022 | 1 | 2022 |